Risk of hospitalization because of aseptic meningitis after measles-mumps-rubella vaccination in one- to two-year-old children: an analysis of the Vaccine Safety Datalink (VSD) Project
- 1 May 1997
- journal article
- research article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 16 (5) , 500-503
- https://doi.org/10.1097/00006454-199705000-00009
Abstract
To assess the level of increased risk, if any, of hospitalizations for aseptic meningitis after Jeryl-Lynn mumps strain measles-mumps-rubella (MMR) vaccine in the Vaccine Safety Datalink population. A possible increased risk of aseptic meningitis 8 to 14 days after receipt of MMR was observed in a preliminary screening analysis of automated data from the Vaccine Safety Datalink (VSD) project Year 2 analysis. To further evaluate this association a retrospective 10-year matched case-control study was undertaken in the four health maintenance organizations (HMOs) in the VSD project. Cases ascertained from a broad scan of the automated data were validated against a standard case definition. Two controls matched on age, sex, HMO and HMO membership were assigned per case. The VSD project involves the cooperative collection of automated vaccination and medical outcome data from four large HMOs that currently have 500 000 children younger than 7 years of age under surveillance. Review of automated screening results from the first 2 years of data revealed a possible increased risk of aseptic meningitis 0 to 14 days after MMR with a relative risk of 3.61 (95% confidence interval, 1.0 to 13.1) although the total number of cases was small. Although the automated data had suggested a possible association of aseptic meningitis with MMR containing the Jeryl-Lynn strain of mumps, review of validated hospitalized cases during the observation period did not reveal evidence of an increased risk of aseptic meningitis after MMR containing the Jeryl-Lynn strain of mumps (odds ratio <1.0 for all analyses). Although it is recognized that hospitalized cases represent a minority of the total cases of aseptic meningitis, it is reassuring that in this evaluation no increased risk of aseptic meningitis after MMR vaccine was found.Keywords
This publication has 6 references indexed in Scilit:
- Utility of Large‐linked Databases in Vaccine Safety, Particularly in Distinguishing Independent and Synergistic EffectsAnnals of the New York Academy of Sciences, 1995
- A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccinesThe Lancet, 1995
- Risk of aseptic meningitis after measles, mumps,and rubella vaccine in UK childrenThe Lancet, 1993
- Mumps meningitis and measles, mumps, and rubella vaccineThe Lancet, 1992
- Aseptic meningitis as a complication of mumps vaccinationThe Pediatric Infectious Disease Journal, 1991
- A prefecture-wide survey of mumps meningitis associated with measles, mumps and rubella vaccineThe Pediatric Infectious Disease Journal, 1991